CG Oncology (CGON) Leases (2023 - 2026)

CG Oncology (CGON) reported Leases of $4.5 million for Q1 2026, up 336.79% on a YoY basis from $1.0 million in Q1 2025, and up 13.62% quarter-over-quarter from $4.0 million in Q4 2025.

CG Oncology (CGON) Leases (2023 - 2026) Analysis & Trends

CG Oncology has reported Leases for 4 years, with the latest figure at $4.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Leases rose 336.79% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (up 336.79% YoY), and the FY2025 full-year result was $4.0 million, up 1696.83% from the prior year.
  • Leases for Q1 2026 stood at $4.5 million, up from $4.0 million in the prior quarter.
  • The five-year high for Leases was $4.5 million in Q1 2026, with the low at $221000.0 in Q4 2024.
  • Historically, Leases has averaged $1.6 million across 4 years, with a median of $693500.0 in 2023.
  • Annual changes were most pronounced in 2024 — Leases sank 47.63% — and 2025, when it surged 1696.83%.
  • CG Oncology's Leases stood at $422000.0 in 2023, then slumped by 47.63% to $221000.0 in 2024, then surged by 1696.83% to $4.0 million in 2025, then increased by 13.62% to $4.5 million in 2026.
  • The last three Leases figures came in at $4.5 million (Q1 2026), $4.0 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Leases (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 61,822.50
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 83,048.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 285.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.69 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 CG Oncology 4.59 Bn 4.59 Bn -1.88 Mn 4.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.51 Mn
Dec 31, 2025 3.97 Mn
Sep 30, 2025 4.20 Mn
Jun 30, 2025 965,000.00
Mar 31, 2025 1.03 Mn
Dec 31, 2024 221,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 329,000.00
Mar 31, 2024 368,000.00
Dec 31, 2023 422,000.00